IMUNON SUBMITS PLAN IN CONSULTATION WITH EXCHANGE TO ENSURE COMPLIANCE WITH NASDAQ'S LISTING REQUIREMENT, ANTICIPATES ADDITIONAL COMPLIANCE PERIOD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.